These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 6456847)
1. Inhibition of DNA synthesis in mouse epidermis and breast epithelium by dehydroepiandrosterone and related steroids. Pashko LL; Schwartz AG; Abou-Gharbia M; Swern D Carcinogenesis; 1981; 2(8):717-21. PubMed ID: 6456847 [TBL] [Abstract][Full Text] [Related]
2. Dehydroepiandrosterone and 16 alpha-bromo-epiandrosterone: inhibitors of Epstein-Barr virus-induced transformation of human lymphocytes. Henderson E; Schwartz A; Pashko L; Abou-Gharbia M; Swern D Carcinogenesis; 1981; 2(7):683-6. PubMed ID: 6268330 [TBL] [Abstract][Full Text] [Related]
3. Dehydroepiandrosterone and 16 alpha-Br-epiandrosterone inhibit 12-O-tetradecanoylphorbol-13-acetate stimulation of superoxide radical production by human polymorphonuclear leukocytes. Whitcomb JM; Schwartz AG Carcinogenesis; 1985 Mar; 6(3):333-5. PubMed ID: 2983900 [TBL] [Abstract][Full Text] [Related]
4. Food restriction inhibits [3H] 7,12-dimethylbenz(a)anthracene binding to mouse skin DNA and tetradecanoylphorbol-13-acetate stimulation of epidermal [3H] thymidine incorporation. Schwartz AG; Pashko LL Anticancer Res; 1986; 6(6):1279-82. PubMed ID: 3101576 [TBL] [Abstract][Full Text] [Related]
5. Novel dehydroepiandrosterone analogues with enhanced biological activity and reduced side effects in mice and rats. Schwartz AG; Lewbart ML; Pashko LL Cancer Res; 1988 Sep; 48(17):4817-22. PubMed ID: 2970293 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor development by dehydroepiandrosterone and related steroids. Schwartz AG; Pashko L; Whitcomb JM Toxicol Pathol; 1986; 14(3):357-62. PubMed ID: 3024302 [TBL] [Abstract][Full Text] [Related]
7. Dehydroepiandrosterone and two structural analogs inhibit 12-O-tetradecanoylphorbol-13-acetate stimulation of prostaglandin E2 content in mouse skin. Hastings LA; Pashko LL; Lewbart ML; Schwartz AG Carcinogenesis; 1988 Jun; 9(6):1099-102. PubMed ID: 2967126 [TBL] [Abstract][Full Text] [Related]
8. Influence of dehydroepiandrosterone on G-6-PD activity and 3H-thymidine uptake of human lymphocytes in vitro. Ennas MG; Laconi S; Dessí S; Milia G; Murru MR; Manconi PE Toxicol Pathol; 1987; 15(2):241-4. PubMed ID: 2956668 [TBL] [Abstract][Full Text] [Related]
9. Effects of dehydroepiandrosterone on obesity and glucose-6-phosphate dehydrogenase activity in the lethal yellow mouse (strain 129/Sv-Ay/Aw). Granholm NH; Staber LD; Wilkin PJ J Exp Zool; 1987 Apr; 242(1):67-74. PubMed ID: 2955075 [TBL] [Abstract][Full Text] [Related]
10. Dehydroepiandrosterone: an anti-obesity and anti-carcinogenic agent. Schwartz AG; Hard GC; Pashko LL; Abou-Gharbia M; Swern D Nutr Cancer; 1981; 3(1):46-53. PubMed ID: 6213940 [TBL] [Abstract][Full Text] [Related]
11. [Inhibition of glucose-6-phosphate dehydrogenase by steroids. 7. Influence of placental G-6-PDH activity on estrogen synthesis from 7-alpha-3H-DHEA, 7-alpha-3H-DHEA sulfate or 7-alpha-3H-DHEA sulfatide]. Hoffmann G; Badens D; Kreuzer A; Oertel GW Endokrinologie; 1973 Jan; 61(1):124-31. PubMed ID: 4267203 [No Abstract] [Full Text] [Related]
12. Inhibition of Trypanosoma brucei glucose-6-phosphate dehydrogenase by human steroids and their effects on the viability of cultured parasites. Cordeiro AT; Thiemann OH; Michels PA Bioorg Med Chem; 2009 Mar; 17(6):2483-9. PubMed ID: 19231202 [TBL] [Abstract][Full Text] [Related]
13. Anti-proliferative action of endogenous dehydroepiandrosterone metabolites on human cancer cell lines. Yoshida S; Honda A; Matsuzaki Y; Fukushima S; Tanaka N; Takagiwa A; Fujimoto Y; Miyazaki H; Salen G Steroids; 2003 Jan; 68(1):73-83. PubMed ID: 12475725 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of growth of HeLa and WI-38 cells by dehydroepiandrosterone and its reversal by ribo- and deoxyribonucleosides. Dworkin CR; Gorman SD; Pashko LL; Cristofalo VJ; Schwartz AG Life Sci; 1986 Apr; 38(16):1451-7. PubMed ID: 2939310 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of dehydroepiandrosterone sulfatide and 16 alpha-halogenated steroids. Abou-Gharbia M; Pashko L; Schwartz A; Swern D J Pharm Sci; 1981 Oct; 70(10):1154-7. PubMed ID: 6457907 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of spontaneous breast cancer formation in female C3H(Avy/a) mice by long-term treatment with dehydroepiandrosterone. Schwartz AG Cancer Res; 1979 Mar; 39(3):1129-32. PubMed ID: 154968 [TBL] [Abstract][Full Text] [Related]
18. 16-bromoepiandrosterone, an activator of the mammalian immune system, inhibits glucose 6-phosphate dehydrogenase from Trypanosoma cruzi and is toxic to these parasites grown in culture. Cordeiro AT; Thiemann OH Bioorg Med Chem; 2010 Jul; 18(13):4762-8. PubMed ID: 20570159 [TBL] [Abstract][Full Text] [Related]
19. Dietary dehydroepiandrosterone inhibits bone marrow and leukemia cell transplants: role of food restriction. Catalina F; Milewich L; Kumar V; Bennett M Exp Biol Med (Maywood); 2003 Dec; 228(11):1303-20. PubMed ID: 14681546 [TBL] [Abstract][Full Text] [Related]
20. Ergosteroids. II: Biologically active metabolites and synthetic derivatives of dehydroepiandrosterone. Lardy H; Kneer N; Wei Y; Partridge B; Marwah P Steroids; 1998 Mar; 63(3):158-65. PubMed ID: 9558717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]